Net worth
$34.9B
Forbes Real-Time · as of Sep 24, 2026
Latest moves
No moves from Thomas Frist Jr & family in the digest yet. The archive grows every morning.
Recent SEC filings
No SEC filings in the last 90 days.
Form 4 insider trades post within 2 business days. 13F fund holdings can arrive 45 days after quarter end. New to filings? Read Filings 101.
Footprint
Companies
HCA Healthcare, Inc. (issuer CIK 0000860730)HCA · NYSE · Co-founder · ~32% · as of Mar 2026 · $423.48 ▼ 2.98%
source ↗More
- Ticker
- HCA
- Exchange
- NYSE
- Role
- Co-founder (1968); Frist founder affiliates together with sponsors collectively own ~32% of common stock per 2026 proxy; son Thomas F. Frist III is board chairman; Frist Group has rights to nominate two directors under Amended and Restated Stockholders' Agreement effective 2026-02-06
- Stake
- ~32% (Frist affiliates collectively)
- Stake as of
- 2026-03-13
Investment vehicles
Hercules Holding IIholding co
source ↗More
- Type
- holding co
- Notes
- Private investor group affiliated with Frist Jr.; held 68,912,077 HCA shares (25.7%) at 2023-12-31; 32,282,889 shares after Feb 2026 restructuring
Frisco Holding IIholding co
source ↗More
- Type
- holding co
- Notes
- Received 36,557,141 HCA shares on 2026-02-06 (Form 4 code J) when Frisco's interest in Hercules was restructured; Frist Jr. reports pecuniary interest of 846,050 shares via Frisco partnership units
Frist family trusts (e.g., William R. Frist 2010 Family Trust, Patricia Frist Elcan 2011 Family Trust, GRATs)trust
source ↗More
- Type
- trust
- Notes
- Named in 13G/A group filing with Frist Jr., Thomas F. Frist III, William R. Frist and Patricia F. Elcan (each ~25.8-25.9% beneficial ownership, with disclaimers) as of 2023-12-31
Frist Cressey Ventures (Funds II-IV) / Frist Capital, LLCfund
source ↗More
- Type
- fund
- Notes
- Nashville healthcare VC entities appearing in EDGAR name search for 'Frist'; link to Frist Jr. personally not verified
Private deals
Restructuring of Hercules Holding II: 36,629,188 HCA shares moved out and 36,557,141 shares acquired by Frisco Holding…Feb 2026
source ↗More
- In full
- Restructuring of Hercules Holding II: 36,629,188 HCA shares moved out and 36,557,141 shares acquired by Frisco Holding II (Form 4 code J, no price); Frist Jr. still reports 478,955 shares directly
- Date
- 2026-02-06
HCA and Frist-affiliated investors amended and restated their stockholders' agreement (Frist Group nomination rights…Feb 2026
source ↗More
- In full
- HCA and Frist-affiliated investors amended and restated their stockholders' agreement (Frist Group nomination rights for two directors)
- Date
- 2026-02-06
Legal & regulatory
HCA Q2 2026: revenue $20.23B, net income $1.699B; ~$400M income hit from payer-mix shift as patients lost exchange…
source ↗More
- In full
- HCA Q2 2026: revenue $20.23B, net income $1.699B; ~$400M income hit from payer-mix shift as patients lost exchange coverage, offset by ~$400M Medicaid supplemental payments (mainly Florida directed payment program); 2026 net income guidance cut to $6.3-6.7B
Giving
Frist Foundation (Nashville); Frist Jr. is also director emeritus of the Frist Art Museum
source ↗Research gaps: Exact Frist family HCA share total/percent in the 2026 proxy ownership table not extracted (only the ~32% combined founder-affiliate/sponsor figure); no Frist family open-market sales found in the 2026 Form 4s reviewed (Feb 2026 was an in-kind J-code restructuring). Other family CIKs seen on EDGAR: Thomas F. Frist III 0001223892, William R. Frist 0001433377. Frist Foundation EIN not verified (ProPublica rate-limited). No verified real estate or trophies. Web search budget exhausted, so press coverage was not checked.
Prices via Finnhub · as of Sep 24, 2026 4:00 PM ET. For information only.
What to watch
HCA $0.78/share quarterly dividend payable (record date Sept 16)Sep 30, 2026
source ↗HCA buybacks: $7.21B authorization remaining after repurchasing $2.064B in Q2 2026; watch for further Frist-entity…
source ↗More
- In full
- HCA buybacks: $7.21B authorization remaining after repurchasing $2.064B in Q2 2026; watch for further Frist-entity transactions on Form 4
Chief Clinical Officer Michael Cuffe steps down Aug 31, 2026, transitional role through Feb 20272026-08-31 to 2027-02
source ↗Exchange-coverage losses vs. Medicaid supplemental payments driving HCA's revised 2026 guidance (Q3 results expected…
source ↗More
- In full
- Exchange-coverage losses vs. Medicaid supplemental payments driving HCA's revised 2026 guidance (Q3 results expected in Q4 2026; date not yet confirmed)